The cytotoxicity promoting effects of SLAMF7-mediated co-stimulation on human CD8+ T cells highlights the potential of the SLAMF7-receptor as a therapeutic target to enhance CD8+ T cell responses leading to improved elimination of virus-infected or tumor cells. The gene discussed is CD8A; the disease is neoplasm.